Abstract Extracellular vesicles and exomere nanoparticles are under intense investigation as sources of clinically relevant cargo. Here we report the discovery of a distinct extracellular nanoparticle, termed supermere. Supermeres are morphologically distinct from exomeres and display a markedly greater uptake in vivo compared with small extracellular vesicles and exomeres. The protein and RNA composition of supermeres differs from small extracellular vesicles and exomeres.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Gregory W. Daniel
President's Message: Develop Your Brand
© Tim Kelly and Kyla Renee Paintings PPA President Gregory Daniel Many years ago, during a long-term goal planning session, my wife, Lesa, and I recognized that our focus on being a general purpose, mom-and-pop studio needed to change. We determined that growth in the 21st century would depend on elevating our images to the level of fine art. As a result of our changed target, we developed a new business model and plan that would transform our studio over the next several years.
President's message: Start today
PPA President Gregory Daniel ©Tim Kelly and Kyla Renee Paintings My wish for each of you is to live your best life in this amazing profession. I cannot think of another occupation that provides such a wonderful lifestyle while giving so much joy not only to your clients but to yourself and your family as well. Photography provides endless opportunities for creating meaningful and lasting relationships with your clients.
Addressing Antimicrobial Resistance and Stewardship: The Priority Antimicrobial Value and Entry (PAVE) Award
Antimicrobial-resistant infections affect more than 2 million people annually in the United States alone, accounting for an estimated 23?000 deaths and estimated economic costs of $55 billion.1 Recent projections suggest that an estimated 300 million people worldwide could die prematurely in the next 35 years because of antimicrobial-resistant infections.2 Physicians are more frequently prescribing antibiotics of last resort (such as colistin and carbapenem), raising concerns that...
Time To Fix The Black Hole In Medicare Data
Every year, the Medicare program pays for nearly 500,000 hip and knee replacement surgeries for America’s seniors. At the same time, approximately 25,000 patients undergo procedures to remove and replace a previous artificial joint, sometimes because it failed before the end of its expected useful life.
Are Priority Review Vouchers The Answer To Incentivize Drug Development? Not So Fast.
In the May issue of Health Affairs, two papers examine the potential for voucher systems to incentivize drug development in areas of unmet medical need. Co-authors Kevin Outterson and Anthony McDonnell take a look at potential exclusivity voucher programs designed to encourage development of new antibiotics, while David Ridley and Stephane Régnier analyze the effects that expansion of existing priority review voucher (PRV) programs may have on the value of PRVs as a development incentive.
U.S. officials must move quickly to combat superbugs
As officials reel from the news that a “superbug” strain of E-coli resistant to colistin, the antibiotic of last resort, has arrived in the United States, leaders in Europe have issued guidance on policy measures aimed at avoiding this worst-case scenario. The U.S. can’t wait any longer; as the United Kingdom and other European countries seem poised to make significant strides, we are running behind. Dangerous bacteria are becoming resistant to antibiotics faster than new drugs can hit the market.
The Path of Least [Antibiotic] Resistance
While antibiotics are necessary and crucial for treating bacterial infections, their misuse over time has contributed to a rather alarming rate of antibiotic resistance, including the development of multidrug-resistance bacteria or “super bugs.” Misuse manifests throughout all corners of public and private life; from the doctor’s office when prescribed to treat viruses; to industrial agriculture, where they are used in abundance to prevent disease in livestock.
Health Policy 101: How the Trans-Pacific Partnership Will Impact Prescription Drugs
For the last several years, the US government has been negotiating a free-trade agreement known as the Trans-Pacific Partnership (TPP) with 11 other countries across the Asia-Pacific and Latin American regions, which could have major impact on the pharmaceutical market. When finalized it will be the largest free-trade agreement in history, impacting up to one-third of world trade and roughly 40 percent of the global gross domestic product.
Strengthening patient care: Building an effective national medical device surveillance system
Medical devices play a critical role in health care. Access to reliable and meaningful information about the safety, effectiveness, and quality of devices is essential to inform care and improve patient outcomes. While the Food and Drug Administration (FDA) has a public health mission to monitor the safety and effectiveness of devices, everyone has a vested interest in improving information about medical products.
Breakthrough therapy designation: A primer
Breakthrough therapy designation (BTD) is the newest of four expedited programs developed by the U.S Food and Drug Administration (FDA) to accelerate the development and review of novel therapies that target serious conditions. The public response to the program has been largely positive, and dozens of drugs have successfully received the designation. However, the FDA denies many more requests than it grants.
Improving Pharmaceutical Innovation By Building A More Comprehensive Database On Drug Development And Use
Over the past several decades new drugs and biologics have had a tremendous impact on the treatment of a wide range of diseases. Better scientific understanding of diseases and their progression, as well as advancements in drug development and regulation, have led to increasingly targeted and sometimes breakthrough treatments. Despite this progress, however, the innovation ecosystem appears to be falling short of its full potential to improve health.
Biomedical Innovation
The goal of biomedical innovation is to maximize scientific discoveries to improve individual health, which has enabled the discovery of life-savings vaccines, and effective treatments for conditions such as heart disease, diabetes, cancer, and common bacterial infections.
5 Questions About the Medical Device Tax, and Its Potential for Repeal
1. What is the medical device tax? Included in the Affordable Care Act (ACA) and launched in 2013, the medical device tax imposes a 2.3 percent sales tax on medical device supplies. The tax applies broadly to a range of products, including pacemakers, artificial joints, surgical gloves, and dental instruments. It does not apply to eyeglasses, contact lenses, hearing aids, wheelchairs, or any other device that the public generally buys for individual use.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Gregory W.
Contact Gregory W., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack